Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 0.67 |
| ▸ | MAOB | P27338 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | DRD2 | P14416 | 2/20 | 0.46 |
| ▸ | DRD3 | P35462 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pterocarpin SCHEMBL29361907 | 1.00 | MAPT (1.00) | MAPTTDP1MAPK1MAOAMAOB | |
| Pterocarpin SCHEMBL1248055 | 1.00 | MAPT (1.00) | MAPTTDP1MAPK1MAOAMAOB | |
| Pterocarpin SCHEMBL3231566 | 0.92 | MAPT (0.85) | MAPTTDP1MAPK1MAOAMAOB | |
| Homopterocarpin SCHEMBL12998414 | 0.89 | MAPT (0.80) | MAPTTDP1MAPK1MAOAMAOB | |
| Homopterocarpin SCHEMBL12810803 | 0.89 | MAPT (0.80) | MAPTTDP1MAPK1MAOAMAOB | |
| Homopterocarpin SCHEMBL12810250 | 0.89 | MAPT (0.80) | MAPTTDP1MAPK1MAOAMAOB | |
| Homopterocarpin SCHEMBL31237481 | 0.89 | MAPT (0.80) | MAPTTDP1MAPK1MAOAMAOB | |
| Homopterocarpin SCHEMBL29366996 | 0.89 | MAPT (0.80) | MAPTTDP1MAPK1MAOAMAOB | |
| SCHEMBL12891389 | 0.83 | MAPT (0.71) | MAPTTDP1MAPK1MAOAMAOB | |
| SCHEMBL18602053 | 0.83 | MAPT (0.71) | MAPTTDP1MAPK1MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011066-A | Preparation method of exogenous indian pterocarpus santalinus glycoside and application thereof in promoting germination of corn seeds | 黑龙江八一农垦大学 | 2026-05-12 | — | — | CN | claimed |
| CN-119745895-A | Traditional Chinese medicine monomer composition for treating rheumatoid arthritis and application thereof | 中日友好医院(中日友好临床医学研究所) | 2025-04-04 | — | — | CN | claimed |
| CN-115109809-B | Midecarin is a biosynthesis method of (2) | 南京中医药大学 | 2025-03-04 | — | — | CN | claimed |
| CN-113588857-B | Quality detection method of radix sophorae tonkinensis and application thereof | 中国人民解放军海军军医大学 | 2024-08-23 | — | — | CN | claimed |
| CN-114200040-B | Content determination method for one-measurement-multiple-evaluation child type open throat sword spray | 贵州三力制药股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116600657-A | Application of naringenin in improving quality of phlorizin taste | 西姆莱斯有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-115869346-A | Method for preparing gel for strengthening body by ultra-moxibustion | 武代媛 | 2023-03-31 | — | — | CN | claimed |
| CN-115109809-A | Biosynthesis method of santalin | 南京中医药大学 | 2022-09-27 | — | — | CN | claimed |
| CN-115068588-A | Application of active ingredients of gorse sinica maxim in preparation of anti-HPV (human papillomavirus) gel | 江西康林药业有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-114437100-A | Method for extracting santalin from sea sword beans and application of santalin | 郑州师范学院 | 2022-05-06 | — | — | CN | claimed |
| EP-2295031-B1 | Use of pterocarpans as anti-cellulite agents | SYMRISE AG (DE) | 2018-01-10 | — | — | EP | claimed |
| EP-2832371-B1 | APPLICATION OF GASTRODIN AS SOLUBILIZER AND METHOD FOR PREPARING INJECTION OR POWDER FOR INJECTION | KPC PHARMACEUTICALS INC (CN) | 2017-02-01 | — | — | EP | claimed |
| CN-105434518-A | Traditional Chinese medicine preparation for treating hepatitis | CHANGSHU LEIYUNSHANG PHARMACEUTICAL CO LTD | 2016-03-30 | — | — | CN | claimed |
| CN-104884035-A | Hair colouring method employing a chromene or chroman dye, a particular organic compound, an oxidizing agent, an alkaline agent and a metal salt | OREAL | 2015-09-02 | — | — | CN | claimed |
| CN-104822424-A | Oral compositions for enhancing skin tolerance following topical application of retinoid compounds | INNEOV LAB | 2015-08-05 | — | — | CN | claimed |
| EP-2832371-A1 | APPLICATION OF GASTRODIN AS SOLUBILIZER AND METHOD FOR PREPARING INJECTION OR POWDER FOR INJECTION | Kunming Pharmaceutical Corp. (CN) | 2015-02-04 | — | — | EP | claimed |
| CN-103349007-A | Agricultural composition containing antibiotics and plant source substances and application thereof | HAINAN ZHENGYE ZHONGNONG HIGH TECHNOLOGY CO LTD | 2013-10-16 | — | — | CN | claimed |
| EP-2295031-A2 | Use of pterocarpans as anti-cellulite agents | Symrise AG (DE) | 2011-03-16 | — | — | EP | claimed |
| US-20110034486-A1 | USE OF PTEROCARPANS AS ACTIVE ANTI-CELLULITE INGREDIENTS | SYMRISE GMBH & CO., KG (DE) | 2011-02-10 | — | — | US | claimed |
| CN-101119711-A | Methods of use of herbal compositions | MEDIGREEN BIOTECHNOLOGY CORP (CN) | 2008-02-06 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034486-A1 | USE OF PTEROCARPANS AS ACTIVE ANTI-CELLULITE INGREDIENTS | FABP4, PLIN1, CPT1B | MAPT 4747/4885TDP1 1491/4885MAPK1 767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.